AI and ML are transforming clinical trials by enhancing efficiency, reducing costs, and improving outcomes. Opportunities include understanding AI/ML fundamentals, optimizing trials, predicting ...

Each summer near Manchester, budding Santas, Mrs. Clauses and their elven companions gather in the woods for three days. It’s ...

If you are wondering whether Invesco is still a smart buy at today’s price, you are not alone, and this article is going to unpack what the current share price really implies. The stock has been on a ...

PSU banks are leading the 2025 rally as NPAs fall to decade lows, RoE stays above 15% and valuations remain below 1x book.

The market is still viewing growth stocks favorably. If a few pieces fall into place, outperformance could continue for a ...

The shares of Meesho dropped more than 8 percent on December 23, extending significant losses for the third consecutive session. This comes after the newly-listed stock rallied 65 percent in just four ...

Recent reforms have addressed long-standing concerns around lock-ins, annuitization and equity exposure, strengthening the ...

Amazon's AWS strength and holiday shopping fuel, Rio Tinto's gold and divestment pivot and Apple's changing AI fortunes ...